Management of Hepatorenal Syndrome–Acute Kidney Injury in Liver Transplant Candidates

Nov 17 2024
Convention Center: Room 28 E
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Shilpa Junna, MD
Discussion Leader

Shilpa Junna, MD

Cleveland Clinic Foundation
PS
Discussion Leader

Pratima Sharma

University of Michigan Medical Center

Description

Experts review the diagnosis, prognosis, and management of hepatorenal syndrome–acute kidney injury (HRS-AKI). Topics include the role of biomarkers in the diagnosis of HRS-AKI, and pharmacologic and nonpharmacologic treatment options in liver transplant candidates.  

Journey Maps

Objectives

  • Review the updated definitions of HRS-AKI.
  • Describe the role of biomarkers in the diagnostic algorithm of HRS-AKI.
  • Discuss the pharmacologic and nonpharmacologic management of HRS-AKI.